Sylvia Burleson says her husband, Erik, always dreamed of being a firefighter, a role they both knew came with risks.

Among individuals with achalasia, male sex, older age and prior esophageal Candida infection increased risk for esophageal ...

Adjuvant nivolumab offered sustained survival benefits in resected esophageal/GEJ cancer post chemoradiation, with PD-L1 ...

When it comes to the use of PD-1 inhibitors in stomach cancer, the FDA has put its money where its mouth is. | After ...

Now, nivolumab -- in combination with chemotherapy -- is indicated for the first-line treatment of adults with unresectable ...

Durvalumab is an IV drug that boosts the immune system’s ability to detect and kill cancer cells. It’s used to treat a range ...

Exercising during chemotherapy and before surgery may help the body send more immune cells into cancerous tumors, according ...

The Gerald E. Connolly Esophageal Cancer Awareness Act of 2025 passed the House on a voice vote as both parties came together ...

A recent trial reveals that durvalumab enhances event-free survival in patients with resectable gastric and gastroesophageal junction adenocarcinoma.

Atezolizumab may improve upon perioperative treatment with trastuzumab and chemotherapy in HER2+, locally advanced, resectable gastric or GEJ cancer, researchers say.